SCHEMBL26732571

SCHEMBL26732571

O=c1[nH]nc(I)c2ccc(Br)cc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 1/20 0.49
▸ WDR77 Q9BQA1 1/20 0.49
▸ JAK2 O60674 3/20 0.46
▸ CHEK1 O14757 3/20 0.46
▸ FLT3 P36888 3/20 0.46
▸ PIM1 P11309 3/20 0.46
▸ DYRK1A Q13627 3/20 0.46
▸ PRKD3 O94806 2/20 0.46
▸ MAP4K4 O95819 2/20 0.46
▸ CSF1R P07333 2/20 0.46
▸ CLK2 P49760 2/20 0.46
▸ MAP4K2 Q12851 2/20 0.46
▸ NTRK3 Q16288 2/20 0.46
▸ AURKB Q96GD4 2/20 0.46
▸ CLK4 Q9HAZ1 2/20 0.46
▸ AURKA O14965 1/20 0.46
▸ DAPK3 O43293 1/20 0.46
▸ PAK4 O96013 1/20 0.46
▸ ABL1 P00519 1/20 0.46
▸ NTRK1 P04629 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30984825 0.79 PRMT5 (0.49) PRMT5WDR77JAK2CHEK1FLT3
SCHEMBL2460969 0.79 PRMT5 (0.49) PRMT5WDR77JAK2CHEK1FLT3
SCHEMBL23526034 0.79 PRMT5 (0.49) PRMT5WDR77JAK2CHEK1FLT3
SCHEMBL29945916 0.79 PRMT5 (0.49) PRMT5WDR77JAK2CHEK1FLT3
SCHEMBL24076903 0.78 PRMT5 (0.48) PRMT5WDR77JAK2CHEK1FLT3
SCHEMBL2029129 0.76 JAK2 (0.63) JAK2CHEK1FLT3PIM1DYRK1A
SCHEMBL1330584 0.76 PDPK1 (0.63) JAK2CHEK1FLT3PIM1DYRK1A
SCHEMBL29490946 0.76 PDPK1 (0.63) JAK2CHEK1FLT3PIM1DYRK1A
SCHEMBL23914628 0.75 PRMT5 (0.46) PRMT5WDR77JAK2CHEK1FLT3
SCHEMBL30984977 0.75 PRMT5 (0.46) PRMT5WDR77JAK2CHEK1FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230357162-A1 COMPOUNDS, COMPOSITIONS AND METHODS TENVIE THERAPEUTICS, INC. 2023-11-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230357162-A1 COMPOUNDS, COMPOSITIONS AND METHODS NLRP3, NLRP1, NOD1 PRMT5 1868/4885WDR77 1384/4885JAK2 3308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback